
Canadian contract development and manufacturing organisation (CDMO) Patheon reported a solid set of financial figures for the second quarter of …
DHL opens up a facility in Mumbai, Recipharm invests in French filling plant, plus updates from Dalton Pharma Services, Particle …

The FDA has sent Pfizer a Complete Response Letter about its rare disease drug tafamidis meglumine. The US regulator is …

The University of Cambridge begins a new collaboration with GlaxoSmithKline today to advance drug discovery and the development of new …
Chiesi has been publicly reprimanded by the PMCPA part for promoting its asthma drug Fostair off-label. The embarrassing slapdown from …

Pfizer has launched a new website called ‘Campaign Against Migraine’ to help migraine sufferers in the US learn more about …
Lord Adebowale, Margaret Casely-Hayford, Dame Moira Gibb and Naguib Kheraj have been confirmed as four new non-executive directors of the …

Janssen is looking to broaden the licence for its prostate cancer pill Zytiga. Zytiga currently has a US and European …

Celgene has announced the appointment of Nicola Redfern as director of market access, Celgene UK and Ireland. Redfern brings a …

Lundbeck will cut 600 jobs from its operations in Europe as its Cipralex parent expiry continues to erode revenue. The …

NICE has launched a new app that allows users to search all medicines listed in the British National Formulary. The …

Merck’s novel insomnia drug suvorexant has improved patients’ ability to fall asleep, according to new data from two Phase III …

NICE is not recommending Roche’s targeted melanoma pill Zelboraf because of its high cost and uncertainties over its survival benefit. …

The use of post-marketing studies for diabetes is being used to sell more medicines rather than for science, according to …

As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

Healthcare specialist Tudor Reilly has strengthened its senior management with the appointment of Conor Griffin as director. He joins the …
Professor Jonathan Montgomery will head up the Health Research Authority, the new organisation that will protect and promote the interests …

Pharma’s use of digital media is posing questions that can’t yet be answered, says the new ABPI president Deepak Khanna. …

AstraZeneca will be cutting 400 jobs from its facility in Sweden, the company has confirmed. Speaking to the TT news …

Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …